Preclinical research strategies for newly approved drugs as reflected in early publication patterns-Reference-Cited by-同舟云学术

Preclinical research strategies for newly approved drugs as reflected in early publication patterns

Published:2015-11-26 Issue:2 Volume:389 Page:187-199
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Köster Ursula,Nolte Ingo,Michel Martin C.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-015-1187-1.pdf

Reference24 articles.

1. Amiri M, Michel MC (2015) Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry. Naunyn Schmiedeberg's Arch Pharmacol 388(6):613–622

2. Bischoff A, Rascher W, Michel MC (1998) Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis. Am J Physiol 275(4):F502–F509

3. Dorsch H, Jurock AE, Schoepe S, Lessl M, Asadullah K (2015) Grants4Targets: an open innovation initiative to foster drug discovery collaborations. Nat Rev Drug Discov 14(1):74–76

4. Eberlin M, Mück T, Michel MC (2012) A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril. Front Pharmacol 3:93

5. Heifetz A, Schertler GFX, Seifert R, Tate CG, Sexton PM, Gurevich VV, Fourmy D, Cherezov V, Marshall FH, Storer RI, Moraes I, Tikhonova IG, Tautermann CS, Hunt P, Ceska T, Hodgson S, Bodkin MJ, Singh S, Law RJ, Biggin PC (2015) GPCR structure, function, drug discovery and crystallography: report from acadmia-industry international conference (UK Royal Society) Chicheley Hall, 1–2 September 2014. Naunyn Schmiedeberg's Arch Pharmacol 388(8):883–903

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Critical Translational Questions for Implementing FLASH in the Clinic;Seminars in Radiation Oncology;2024-07

2. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-05-11

3. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-04-16

4. Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data;Frontiers in Pharmacology;2016-12-06

5. Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugs;Naunyn-Schmiedeberg's Archives of Pharmacology;2015-11-26